To explore ACSBG1’s function and potential as a therapeutic target in XALD, we created an ACSBG1 knockout (Acsbg1−/−) mouse and examined the effects on brain FA metabolism during development. This evidence concerns the gene ACSBG1 and X-linked adrenoleukodystrophy.